Optiscan Featured in Health Leader TV 2022
Posted: 4 October Part of the Australasian College of Health Service Management (ACHSM), Health Leader TV is a leading and trusted source of health service management information across the Australasian region. They provide best practice information, cutting-edge research…
Aculeus Therapeutics announces IND-enabling studies to advance lead program ACU-0943 towards clinical trials
Posted: 3 October Aculeus Therapeutics is a life sciences company focused on discovering and developing novel immunotherapies to treat a range of serious diseases. Today, Aculeus announced that it has initiated Investigational New Drug, or IND-enabling, studies for…
New $2.5m genomics project boosts precision medicine
Posted: 27 September The funding from the Medical Research Future Fund (MRFF) Genomics Health Futures Mission will support research to harness the full potential of genomic data to improve diagnosis and inform clinical care for all patients who…
Cartherics-led Consortium Receives $5.4M Federal Funding for Cellular Immunotherapy Research into Ovarian and Gastric Cancers
Posted: 27 September Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, together within partner institutions, has received $5.4M Medical Research Futures Fund (MRFF) grant to develop a new approach to enhance cancer therapy…
Immutep Receives A$2.7 million R&D Tax Incentive from French Government
Posted: 26 September Immutep Limited, a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a A$2,693,046 research and development (R&D) tax incentive payment in cash from…
$39 million for research partnerships to improve delivery of healthcare
Posted: 26 September The Partnership Projects Scheme provided $14 million from NHMRC and attracted more than $25 million in additional funding from more than 60 partners, with a total of $39 million invested in collaboration between researchers, policy makers…
4DMedical formalises relationship with the University of Melbourne
Posted: 14 September The longstanding relationship between 4DMedcial and its primary research and academic partner, the University of Melbourne, has been formalised through signing of a Memorandum of Understanding (MoU). The two organisations collaborate in a number of…
New Alzheimer’s disease research launches at the Bionics Institute
Posted: 14 September Bionics Institute welcomes Professor Kate Hoy and her team to lead research into a new treatment for Alzheimer’s disease, the most common form of dementia. Professor Hoy joins us from Monash University where she was…
Governor of Victoria Export Awards – International Health Category Sponsor
Posted: 14 September BioMelbourne Network is a proud sponsor of the Governor of Victoria Export Award in the International Health Category. The annual Governor of Victoria Export Awards (GOVEA) recognise and celebrate excellence and success of Victoria’s best…
Parkville Precinct – Haymarket Roundabout Review
Posted: 14 September BioMelbourne Network joined with 17 institutions resident in the Parkville Biomedical Precinct to advocate for the redevelopment and reform of the infamous Haymarket Roundabout on Flemington Road. The Parkville Biomedical Precinct is now a globally…
GSK Boronia Site Redevelopment – Industry Reference Group (IRG)
Posted: 14 September In June 2022, the Department of Jobs, Precincts and Regions (the department) invited BioMelbourne Network to join an Industry Reference Group (IRG) to help contribute to discussions to support potential options for the GSK Boronia…
Global pandemic therapeutics centre announced in Melbourne
Posted: 13 September Creating a second shield to protect humanity from future pandemics is the principal objective of a new global medical research centre being created in Melbourne. Greater resilience for societies around the world in dealing with…
